Cover Image
Market Research Report

Opportunity Analysis for Biosimilars - South Korea

Published by Frost & Sullivan Product code 249890
Published Content info
Delivery time: 1-2 business days
Not Available
Back to Top
Opportunity Analysis for Biosimilars - South Korea
Published: September 5, 2012 Content info:

This publication has been discontinued on July 2, 2018.



Patent Expiry of Biologics to Provide Potential Growth for Biosimilars

This research service presents an overview of the South Korean biosimilars market and analyzes the opportunities that lay ahead for different stakeholders in the development, manufacturing, and commercialization of biosimilars. This service divides the market into therapeutic proteins and monoclonal antibodies. Further, it aims to present an overview of the global biosimilars market and covers impending patent expiries for biologics, regulatory guidelines, pipeline data, and important participants in the market. Moreover, key market challenges, drivers, and restraints are discussed. The forecast period extends through 2015, with a base year of 2010.

Key Questions This Study Will Answer

  • What are the key factors driving the market, and what are the barriers that need to be resolved?
  • What is the current scenario for the South Korean biosmilars market, and how long will this scenario last?
  • What are the major market segments, and what are their important trends?
  • Who are the key market participants involved, and where do they stand?
  • What is the future of the biosimilars market in South Korea, and what should market participants do to succeed?
Table of Contents
Product Code: P601-01-00-00-00

Table of Contents

  • 1. Executive Summary
  • 2. Market Overview
  • 3. Total Market
    • External Challenges: Drivers and Restraints
    • Forecast and Trends
  • 4. Regulatory Developments
  • 5. Competitors
  • 6. Company Profiles
  • 7. The Last Word (Conclusions and Implications)
  • 8. Appendix
  • 9. Decision Support Database
Back to Top